A detailed history of Citigroup Inc transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Citigroup Inc holds 25 shares of TOI stock, worth $3. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 40 37.5%
Holding current value
$3
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.28 - $0.56 $4 - $8
-15 Reduced 37.5%
25 $0
Q2 2024

Aug 12, 2024

SELL
$0.41 - $1.59 $5,253 - $20,374
-12,814 Reduced 99.69%
40 $0
Q1 2024

May 10, 2024

BUY
$1.36 - $2.3 $16,804 - $28,418
12,356 Added 2481.12%
12,854 $20,000
Q2 2023

Aug 10, 2023

BUY
$0.35 - $0.72 $174 - $358
498 New
498 $0
Q4 2022

Feb 09, 2023

SELL
$0.88 - $5.22 $258 - $1,534
-294 Reduced 55.58%
235 $0
Q3 2022

Nov 10, 2022

SELL
$0.71 - $7.4 $431 - $4,499
-608 Reduced 53.47%
529 $2,000
Q2 2022

Aug 10, 2022

BUY
$4.78 - $9.89 $5,434 - $11,244
1,137 New
1,137 $6,000

Others Institutions Holding TOI

About Oncology Institute, Inc.


  • Ticker TOI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 73,495,504
  • Market Cap $11M
  • Description
  • The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...
More about TOI
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.